Discover the Best Stocks and Maximize Your Portfolio:
- See what stocks are receiving strong buy ratings from top-rated analysts.
- Filter, analyze, and streamline your search for investment opportunities with TipRanks’ Stock Screener.
Cronos Australia Ltd. ( (AU:VIT) ) has shared an update.
Vitura Health Limited announced a $5.1 million investment from Professor Khalil Shahin through a share subscription agreement with AFO Investments. This investment will fund the purchase of Candor Medical and other expansion plans, expected to significantly boost Vitura’s revenue and earnings. The involvement of Shahin, a notable business leader, validates Vitura’s growth strategy and market potential, marking a positive impact on the company’s operations and stakeholder confidence.
More about Cronos Australia Ltd.
Vitura Health Limited is a diversified digital health business listed on the ASX, offering a range of services through its subsidiaries. These include Burleigh Heads Cannabis, which operates Canview, an online ecosystem for prescribers, patients, and pharmacies selling therapeutic products. The company also runs Doctors on Demand, a telehealth platform, and holds interests in psychedelic product distribution and medicinal cannabis clinics such as CDA Clinics and Cannadoc Health Pty Ltd.
YTD Price Performance: -3.66%
Average Trading Volume: 290,888
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$43.04M
Find detailed analytics on VIT stock on TipRanks’ Stock Analysis page.
